Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis.
about
Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectivesTetracyclines in malariaDrug repurposing and human parasitic protozoan diseasesA nondiscriminating glutamyl-tRNA synthetase in the plasmodium apicoplast: the first enzyme in an indirect aminoacylation pathwayYcf93 (Orf105), a small apicoplast-encoded membrane protein in the relict plastid of the malaria parasite Plasmodium falciparum that is conserved in ApicomplexaHigh-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent MalariaSafety, tolerability, and compliance with long-term antimalarial chemoprophylaxis in American soldiers in AfghanistanAn intricate case of multidrug resistant Plasmodium falciparum isolate imported from CambodiaAntimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine.Doxycycline and suicidality.Antibiotics in ingested human blood affect the mosquito microbiota and capacity to transmit malaria.Identifying apicoplast-targeting antimalarials using high-throughput compatible approachesProphylaxis of malaria.Compliance with antimalaria chemoprophylaxis in a combat zone.Rational Risk-Benefit Decision-Making in the Setting of Military Mefloquine PolicyEpidemiological and entomological studies of a malaria outbreak among French armed forces deployed at illegal gold mining sites reveal new aspects of the disease's transmission in French GuianaIncidence of malaria among mosquito collectors conducting human landing catches in western Kenya.In vitro and in vivo antimalarial efficacies of optimized tetracyclines.Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?Severity of imported malaria: protective effect of taking malaria chemoprophylaxisAdvice for families traveling to developing countries with young children.Adverse neuropsychiatric effects of antimalarial drugs.Guidelines for the prevention of travel-associated illness in older adults.Preventative health advice for families moving to developing countries.The growing pipeline of natural aminoacyl-tRNA synthetase inhibitors for malaria treatment.Reduced in vitro doxycycline susceptibility in plasmodium falciparum field isolates from Kenya is associated with PfTetQ KYNNNN sequence polymorphism.Copper(ii) mixed-ligand polypyridyl complexes with doxycycline - structures and biological evaluation.Biological Studies and Target Engagement of the 2-C-Methyl-d-Erythritol 4-Phosphate Cytidylyltransferase (IspD)-Targeting Antimalarial Agent (1R,3S)-MMV008138 and Analogs.Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.Malaria and TravellersInjectable anti-malarials revisited: discovery and development of new agents to protect against malaria
P2860
Q26743363-6361526A-AE1B-4BFE-BFF0-6EDDEFCDD49BQ26778176-F9C279A9-A153-4D0A-89CD-36098C97EDACQ26999453-6E34FF98-C700-4664-8A70-FFB6D9E0D6A1Q27976469-170789BA-795C-4E80-B2DF-F156C90FD992Q28541959-C982CB3A-32F3-401B-8B7B-800A7B0ED242Q28829342-95607C28-373F-431D-AAAC-9465F11ABBFCQ32944212-B6530657-B31A-4B02-964B-F9246688349AQ33564391-7946C6B1-1318-4C9B-B91F-8E71213FA1E9Q33806574-9389C802-C98C-4FFD-BFEB-90B3D11F91AFQ34438960-8752D97E-24D3-49B6-9F92-2DFD47D98364Q34658409-1EAA7DC2-F4F9-4FFA-9032-BB6B83693879Q35114250-92187180-17FC-4F86-A2A8-133C6592B56FQ35225061-B4E1674C-7B40-4929-87D6-3D6636C8B8EFQ36091888-7B002489-0347-4A97-82A7-90B24CC01D69Q36112235-C54E1288-2DC4-4631-90E9-90B9E3273AE8Q36249925-1E3D7CEA-E136-437F-B07D-766FCB817F93Q36489841-119578C5-7BCF-494B-9D57-41A5F1077F0FQ36641794-CFDC187B-17D5-43A2-89EB-38AA1F2FA785Q36969972-8F6EF983-D440-43F9-95C7-2C3D83E3F25EQ36981470-B45AB158-F900-49FF-AE5E-7D7B6D648B3BQ37071767-F8DB848B-98DC-4FC1-BCA1-C20DF5DA6826Q38112517-6E9F0CAA-56F1-49A4-BAB9-DA2C839E0ED2Q38808162-C927309D-B404-49A8-A1FA-25B4C6120233Q40061282-1A01A677-CD81-46F4-A3E1-20E979E22BA5Q40234320-0C26208F-F896-4096-AC30-0E5B9D17942AQ41772359-DCD7E96E-CC25-45C8-BD46-5E84B56CF100Q41867026-AFE3FDBB-873B-46E4-B5AD-C4A6886B9D8CQ41915967-246E72E7-69AF-4903-B0B8-6AADD0A99427Q45071037-C42A957B-2117-4F36-8024-7E7934E8D303Q50041817-5B7CCBA3-4487-49F9-803B-3435B20881B7Q58214241-AE8083BC-6E11-4037-B26A-F2C4D4623364Q58566399-63F26B55-5A40-4377-90A7-49F59FF3B42F
P2860
Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Doxycycline for malaria chemop ...... g on malaria chemoprophylaxis.
@ast
Doxycycline for malaria chemop ...... g on malaria chemoprophylaxis.
@en
Doxycycline for malaria chemop ...... g on malaria chemoprophylaxis.
@nl
type
label
Doxycycline for malaria chemop ...... g on malaria chemoprophylaxis.
@ast
Doxycycline for malaria chemop ...... g on malaria chemoprophylaxis.
@en
Doxycycline for malaria chemop ...... g on malaria chemoprophylaxis.
@nl
prefLabel
Doxycycline for malaria chemop ...... g on malaria chemoprophylaxis.
@ast
Doxycycline for malaria chemop ...... g on malaria chemoprophylaxis.
@en
Doxycycline for malaria chemop ...... g on malaria chemoprophylaxis.
@nl
P2093
P2860
P1476
Doxycycline for malaria chemop ...... g on malaria chemoprophylaxis.
@en
P2093
Alan J Magill
Kathrine R Tan
Monica E Parise
Paul M Arguin
P2860
P304
P356
10.4269/AJTMH.2011.10-0285
P407
P577
2011-04-01T00:00:00Z